Amcor Total Cost of Revenue increased by 7.1% to $4.72B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 76.3%, from $2.68B to $4.72B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 4.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.71B | $2.77B | $2.86B | $2.98B | $3.12B | $3.04B | $2.98B | $2.99B | $2.95B | $2.80B | $2.63B | $2.72B | $2.78B | $2.69B | $2.62B | $2.68B | $4.19B | $4.62B | $4.41B | $4.72B |
| QoQ Change | — | +2.3% | +3.3% | +4.0% | +4.6% | -2.3% | -2.1% | +0.5% | -1.4% | -5.2% | -6.0% | +3.4% | +2.3% | -3.1% | -2.9% | +2.4% | +56.3% | +10.4% | -4.6% | +7.1% |
| YoY Change | — | — | — | — | +15.0% | +9.9% | +4.1% | +0.6% | -5.3% | -8.1% | -11.7% | -9.2% | -5.8% | -3.7% | -0.6% | -1.5% | +50.6% | +71.5% | +68.6% | +76.3% |